Literature DB >> 16378996

Monoclonal antibodies targeting the HR2 domain and the region immediately upstream of the HR2 of the S protein neutralize in vitro infection of severe acute respiratory syndrome coronavirus.

Kuo-Ming Lip1, Shuo Shen, Xiaoming Yang, Choong-Tat Keng, Aihua Zhang, Hsueh-Ling Janice Oh, Zhi-Hong Li, Le-Ann Hwang, Chih-Fong Chou, Burtram C Fielding, Timothy H P Tan, Josef Mayrhofer, Falko G Falkner, Jianlin Fu, Seng Gee Lim, Wanjin Hong, Yee-Joo Tan.   

Abstract

We have previously shown that an Escherichia coli-expressed, denatured spike (S) protein fragment of the severe acute respiratory coronavirus, containing residues 1029 to 1192 which include the heptad repeat 2 (HR2) domain, was able to induce neutralizing polyclonal antibodies (C. T. Keng, A. Zhang, S. Shen, K. M. Lip, B. C. Fielding, T. H. Tan, C. F. Chou, C. B. Loh, S. Wang, J. Fu, X. Yang, S. G. Lim, W. Hong, and Y. J. Tan, J. Virol. 79:3289-3296, 2005). In this study, monoclonal antibodies (MAbs) were raised against this fragment to identify the linear neutralizing epitopes in the functional domain and to investigate the mechanisms involved in neutralization. Eighteen hybridomas secreting the S protein-specific MAbs were obtained. Binding sites of these MAbs were mapped to four linear epitopes. Two of them were located within the HR2 region and two immediately upstream of the HR2 domain. MAbs targeting these epitopes showed in vitro neutralizing activities and were able to inhibit cell-cell membrane fusion. These results provide evidence of novel neutralizing epitopes that are located in the HR2 domain and the spacer region immediately upstream of the HR2 of the S protein.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16378996      PMCID: PMC1346840          DOI: 10.1128/JVI.80.2.941-950.2006

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  41 in total

Review 1.  Mechanisms of viral membrane fusion and its inhibition.

Authors:  D M Eckert; P S Kim
Journal:  Annu Rev Biochem       Date:  2001       Impact factor: 23.643

2.  Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry.

Authors:  Graham Simmons; Jacqueline D Reeves; Andrew J Rennekamp; Sean M Amberg; Andrew J Piefer; Paul Bates
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-09       Impact factor: 11.205

3.  Neutralization synergy of human immunodeficiency virus type 1 primary isolates by cocktails of broadly neutralizing antibodies.

Authors:  M B Zwick; M Wang; P Poignard; G Stiegler; H Katinger; D R Burton; P W Parren
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

Review 4.  Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin.

Authors:  J J Skehel; D C Wiley
Journal:  Annu Rev Biochem       Date:  2000       Impact factor: 23.643

5.  Functional analysis of an epitope in the S2 subunit of the murine coronavirus spike protein: involvement in fusion activity.

Authors:  Fumihiro Taguchi; Yohko K Shimazaki
Journal:  J Gen Virol       Date:  2000-12       Impact factor: 3.891

6.  The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex.

Authors:  Berend Jan Bosch; Ruurd van der Zee; Cornelis A M de Haan; Peter J M Rottier
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

7.  The entry of entry inhibitors: a fusion of science and medicine.

Authors:  John P Moore; Robert W Doms
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-05       Impact factor: 11.205

8.  Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association.

Authors:  Jianhua Sui; Wenhui Li; Akikazu Murakami; Azaibi Tamin; Leslie J Matthews; Swee Kee Wong; Michael J Moore; Aimee St Clair Tallarico; Mobolaji Olurinde; Hyeryun Choe; Larry J Anderson; William J Bellini; Michael Farzan; Wayne A Marasco
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-24       Impact factor: 11.205

9.  Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus.

Authors:  Wenhui Li; Michael J Moore; Natalya Vasilieva; Jianhua Sui; Swee Kee Wong; Michael A Berne; Mohan Somasundaran; John L Sullivan; Katherine Luzuriaga; Thomas C Greenough; Hyeryun Choe; Michael Farzan
Journal:  Nature       Date:  2003-11-27       Impact factor: 49.962

10.  A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2.

Authors:  Swee Kee Wong; Wenhui Li; Michael J Moore; Hyeryun Choe; Michael Farzan
Journal:  J Biol Chem       Date:  2003-12-11       Impact factor: 5.157

View more
  53 in total

1.  Effects of human anti-spike protein receptor binding domain antibodies on severe acute respiratory syndrome coronavirus neutralization escape and fitness.

Authors:  Jianhua Sui; Meagan Deming; Barry Rockx; Robert C Liddington; Quan Karen Zhu; Ralph S Baric; Wayne A Marasco
Journal:  J Virol       Date:  2014-09-17       Impact factor: 5.103

2.  A conserved immunogenic and vulnerable site on the coronavirus spike protein delineated by cross-reactive monoclonal antibodies.

Authors:  Chunyan Wang; Rien van Haperen; Javier Gutiérrez-Álvarez; Wentao Li; Nisreen M A Okba; Irina Albulescu; Ivy Widjaja; Brenda van Dieren; Raul Fernandez-Delgado; Isabel Sola; Daniel L Hurdiss; Olalekan Daramola; Frank Grosveld; Frank J M van Kuppeveld; Bart L Haagmans; Luis Enjuanes; Dubravka Drabek; Berend-Jan Bosch
Journal:  Nat Commun       Date:  2021-03-17       Impact factor: 14.919

3.  Coronavirus Entry Inhibitors.

Authors:  Qiaoshuai Lan; Shuai Xia; Lu Lu
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

4.  IgG targeting distinct seasonal coronavirus- conserved SARS-CoV-2 spike subdomains correlates with differential COVID-19 disease outcomes.

Authors:  Jose L Garrido; Matías A Medina; Felipe Bravo; Sarah McGee; Francisco Fuentes-Villalobos; Mario Calvo; Yazmin Pinos; James W Bowman; Christopher D Bahl; Maria Ines Barria; Rebecca A Brachman; Raymond A Alvarez
Journal:  Cell Rep       Date:  2022-05-16       Impact factor: 9.995

Review 5.  Long-Term Immunity and Antibody Response: Challenges for Developing Efficient COVID-19 Vaccines.

Authors:  Mohammad Reza Sepand; Banafsheh Bigdelou; Jim Q Ho; Mohammad Sharaf; Alexis J Lannigan; Ian M Sullivan; Alecsander P da Silva; Leland O Barrett; Scott McGoldrick; Yuvraj Lnu; Shannon E Lynch; Jared M Boisclair; Dakarai D Barnard-Pratt; Steven Zanganeh
Journal:  Antibodies (Basel)       Date:  2022-05-12

6.  Induction of apoptosis by the severe acute respiratory syndrome coronavirus 7a protein is dependent on its interaction with the Bcl-XL protein.

Authors:  Ying-Xim Tan; Timothy H P Tan; Marvin J-R Lee; Puay-Yoke Tham; Vithiagaran Gunalan; Julian Druce; Chris Birch; Mike Catton; Nai Yang Fu; Victor C Yu; Yee-Joo Tan
Journal:  J Virol       Date:  2007-04-11       Impact factor: 5.103

7.  Breadth and function of antibody response to acute SARS-CoV-2 infection in humans.

Authors:  Kuan-Ying A Huang; Tiong Kit Tan; Ting-Hua Chen; Chung-Guei Huang; Ruth Harvey; Saira Hussain; Cheng-Pin Chen; Adam Harding; Javier Gilbert-Jaramillo; Xu Liu; Michael Knight; Lisa Schimanski; Shin-Ru Shih; Yi-Chun Lin; Chien-Yu Cheng; Shu-Hsing Cheng; Yhu-Chering Huang; Tzou-Yien Lin; Jia-Tsrong Jan; Che Ma; William James; Rodney S Daniels; John W McCauley; Pramila Rijal; Alain R Townsend
Journal:  PLoS Pathog       Date:  2021-02-26       Impact factor: 6.823

8.  Highly feasible immunoprotective multicistronic SARS-CoV-2 vaccine candidate blending novel eukaryotic expression and Salmonella bactofection.

Authors:  Vijayakumar Jawalagatti; Perumalraja Kirthika; Ji-Young Park; Chamith Hewawaduge; John Hwa Lee
Journal:  J Adv Res       Date:  2021-07-22       Impact factor: 10.479

9.  Neutralizing Monoclonal Antibodies Inhibit SARS-CoV-2 Infection through Blocking Membrane Fusion.

Authors:  Chia-Jung Li; Tai-Ling Chao; Ting-Yu Chang; Chia-Chun Hsiao; De-Chao Lu; Yi-Wei Chiang; Guan-Chun Lai; Ya-Min Tsai; Jun-Tung Fang; Siman Ieong; Jann-Tay Wang; Sui-Yuan Chang; Shih-Chung Chang
Journal:  Microbiol Spectr       Date:  2022-03-16

10.  Human monoclonal antibodies against highly conserved HR1 and HR2 domains of the SARS-CoV spike protein are more broadly neutralizing.

Authors:  Hatem A Elshabrawy; Melissa M Coughlin; Susan C Baker; Bellur S Prabhakar
Journal:  PLoS One       Date:  2012-11-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.